Showing results (321-330 of 337) with videos related to

Sort By:
Pageof 34
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 30, 2014
[Clinical characteristics and long-term follow-up of 29 patients with primary mediastinal large B cell lymphoma]Bing-Jie Wang, Xi-Nan Cen, Zhi-Xiang Qiu, et al.
CNS Neuroscience & Therapeutics|January 23, 2015
Surgical stress induces brain-derived neurotrophic factor reduction and postoperative cognitive dysfunction via glucocorticoid receptor phosphorylation in aged miceXiao-Sheng Tian, Ya-Wei Tong, Zheng-Qian Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 22, 2009
[A prospective multicenter study of rituximab combined with high-dose chemotherapy and autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma]Yuan-kai Shi, Sheng Yang, Xiao-hong Han, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 4, 2024
AI-based digital pathology provides newer insights into lifestyle intervention-induced fibrosis regression in MASLD: An exploratory studyHai-Yang Yuan, Xiao-Fei Tong, Ya-Yun Ren, et al.
Chinese Medical Journal|June 16, 2021
A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in ChinaZhen-Yang Gu, Yu-Jun Dong, Xiao-Rui Fu, et al.
Frontiers in Microbiology|June 18, 2020
A Novel miRNA-hlo-miR-2-Serves as a Regulatory Factor That Controls Molting Events by Targeting CPR1 in <i>Haemaphysalis longicornis</i> NymphsWen-Ge Liu, Jin Luo, Qiao-Yun Ren, et al.
JHEP Reports : Innovation in Hepatology|May 5, 2025
Liver fibrosis progression analyzed with AI predicts renal declineDan-Qin Sun, Jia-Qi Shen, Xiao-Fei Tong, et al.
Frontiers in Oncology|June 26, 2023
Assessing the decision quality of artificial intelligence and oncologists of different experience in different regions in breast cancer treatmentChunguang Han, Yubo Pan, Chang Liu, et al.
Journal of Hematology & Oncology|September 16, 2021
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 updateXiao-Hui Zhang, Jing Chen, Ming-Zhe Han, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 18, 2019
[Pathological Features, Treatment Options and Prognosis Assessment of Patients with Bone Lymphoma in Real-World]Jin-Ping Ou, Shuang Gao, Li-Hong Wang, et al.
Pageof 34